RE:Explains a lot…QUOTE: Dr. Warren Chan, Director of the Institute of Bioengineering at the University of Toronto, commented, "The biocompatibility of nanomaterials will be an important component to the unlocking of new, potentially life-saving, medical nanotechnology applications and so our study will explore Sona Nanotech's gold nanorods as a safe, non-toxic material for use 'in-vivo'."
Sona Nanotech president and Chief Scientific Officer, Darren Rowles commented, "We are delighted to be working with Dr. Chan, one of the most important nanotechnology scientists in the world, and we are excited to explore with him the unique attributes and benefits our technology may bring to enabling new, important biomedical applications."
Hilited for those that have trouble understanding the level of importance..!
Kaiser wrote: This would explain why they haven't sold any of their "disruptive" gnr tech. Just starting studies of biocompatibility... what is going on here. The company on multiple occasions mentioned how their gnr tech set them apart from everyone else.
the market sees this nr as another load of fluff.
"This program will seek to substantiate the biocompatibility of Sona's proprietary, gold nanorod manufacturing processes and provide a foundation for further research programs"